C.K. McWhorter Cancels J.P. Morgan Communications, Citing Lack of Inclusivity in Minority Banking Initiatives
March 26, 2024 13:38 ET
|
McWhorter Foundation
C.K. McWhorter Cancels J.P. Morgan Communications, Citing Lack of Inclusivity in Minority Banking Initiatives
Exagen Inc. Announces Select Preliminary Full-Year 2023 Results and Reaffirms Guidance
January 07, 2024 12:00 ET
|
Exagen Inc.
CARLSBAD, Calif., Jan. 07, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announces select preliminary unaudited financial results for...
ExCellThera rencontrera les investisseurs durant la 42e conférence annuelle J.P. Morgan Healthcare et participera aux prochaines conférences d'investisseurs
January 02, 2024 07:00 ET
|
ExCellThera
MONTREAL, 02 janv. 2024 (GLOBE NEWSWIRE) -- ExCellThera Inc. (ExCellThera), un leader mondial des thérapies à base de cellules souches sanguines amplifiées, a annoncé aujourd'hui que ses hauts...
ExCellThera to Conduct Investor Meetings During the J.P. Morgan 42nd Annual Healthcare Conference and to Participate in Upcoming Investor Conferences
January 02, 2024 07:00 ET
|
ExCellThera
ExCellThera senior leaders will be holding investor meetings during JP Morgan Heathcare Conference and participating in upcoming investor conferences.
ITM to Present at the 42nd Annual J.P. Morgan Healthcare Conference
December 21, 2023 08:00 ET
|
ITM Isotope Technologies Munich SE
Garching / Munich, Germany, December 21, 2023 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced that CEO, Steffen Schuster and CFO, Dr. Klaus...
SOPHiA GENETICS to Present at the J.P. Morgan 2024 Healthcare Conference
December 14, 2023 12:43 ET
|
SOPHiA GENETICS, Inc.
BOSTON and ROLLE, Switzerland, Dec. 14, 2023 (GLOBE NEWSWIRE) -- SOPHiA GENETICS (NASDAQ: SOPH) today announced that Jurgi Camblong, PhD., Chief Executive Officer and Co-founder, is scheduled to...
FIRST REPUBLIC BANK INVESTOR ALERT: Kaplan Fox Announces Investigation of First Republic Bank on Behalf of Investors
March 16, 2023 15:57 ET
|
Kaplan Fox & Kilsheimer LLP
NEW YORK, March 16, 2023 (GLOBE NEWSWIRE) -- Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating claims on behalf of investors of First Republic Bank (“First Republic” or the...
Axiom Real-Time Metrics Attending J.P. Morgan Healthcare and Biotech Showcase Conferences
January 08, 2023 22:06 ET
|
Axiom Real-Time Metrics Inc
TORONTO, Jan. 08, 2023 (GLOBE NEWSWIRE) -- Axiom Real-Time Metrics ("Axiom"), a premier provider of unified eClinical solutions and services focused on small-to-medium life science organizations,...
Diaccurate est soutenue par Bpifrance pour son Programme DIACC2020 portant sur le développement de nouveaux composés cytotoxiques conjugués à des anticorps thérapeutiques (ADCs)
January 05, 2023 02:00 ET
|
DIACCURATE
La plateforme DIACC2020 ambitionne de mettre au point une nouvelle génération de composés cytotoxiques pouvant être conjugués à des anticorps thérapeutiquesElle s’appuie sur les propriétés uniques du...
Diaccurate receives support from Bpifrance to conduct its DIACC2020 Program on the development of new payloads for antibody-drug conjugates (ADCs)
January 05, 2023 02:00 ET
|
DIACCURATE
The DIACC2020 platform aims to develop a new generation of cytotoxic compounds to be conjugated to therapeutic antibodies The Program stems from the unique properties of its proprietary compound...